...
首页> 外文期刊>BMC Ophthalmology >Role of inflammation in previously untreated macular edema with branch retinal vein occlusion
【24h】

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion

机译:炎症在先前未治疗的视网膜黄斑水肿伴视网膜分支静脉阻塞中的作用

获取原文
           

摘要

Background The association of inflammatory factors and the aqueous flare value with macular edema in branch retinal vein occlusion (BRVO) patients remains unclear. The relationship between the aqueous flare value and the vitreous fluid levels of vascular endothelial growth factor (VEGF), interleukin (IL)-6, monocyte chemotactic protein (MCP)-1, soluble intercellular adhesion molecule 1 (sICAM-1), and soluble VEGF receptor-2 (sVEGFR-2) was evaluated to investigate the role of inflammation in BRVO associated with macular edema. Aqueous flare values and the vitreous levels of VEGF, IL-6, MCP-1, sICAM-1, and sVEGFR-2 were compared between previously untreated patients with BRVO and patients with macular hole (MH). Methods Vitreous samples were obtained from 45 patients during vitreoretinal surgery (28 patients with BRVO and 17 with MH), and the levels of VEGF, IL-6, MCP-1, sICAM-1, and sVEGFR-2 were measured by enzyme-linked immunosorbent assay. Retinal ischemia was evaluated by measuring the area of capillary non-perfusion using fluorescein angiography and the Scion Image program. Aqueous flare values were measured with a laser flare meter and macular edema was examined by optical coherence tomography. Results The median aqueous flare value was significantly higher in the BRVO group (12.1 photon counts/ms) than in the MH group (4.5 photon counts/ms, P?P?=?0.005; ρ?=?0.56, P?=?0.004; ρ?=?0.52, P?=?0.006; and ρ?=?0.47, P?=?0.015, respectively). The aqueous flare value was also significantly correlated with the foveal thickness in the BRVO group (ρ?=?0.40, P?=?0.037). Conclusions Inflammation may induce an increase of vascular permeability and disrupt the blood-aqueous barrier via release of inflammatory factors (VEGF, IL-6, MCP-1, and sICAM-1) in BRVO patients with macular edema.
机译:背景技术视网膜分支静脉阻塞(BRVO)患者中炎症因子和房水耀斑值与黄斑水肿的关系尚不清楚。血管内皮生长因子(VEGF),白介素(IL)-6,单核细胞趋化蛋白(MCP)-1,可溶性细胞间粘附分子1(sICAM-1)和可溶性的液体耀斑值与玻璃体液水平之间的关系评估了VEGF受体2(sVEGFR-2),以研究炎症在与黄斑水肿相关的BRVO中的作用。比较先前未接受BRVO治疗的患者和黄斑裂孔(MH)患者的水斑值和VEGF,IL-6,MCP-1,sICAM-1和sVEGFR-2的玻璃体水平。方法对45例玻璃体视网膜手术患者(28例BRVO患者和17例MH患者)进行玻璃体标本提取,并用酶联免疫法测定VEGF,IL-6,MCP-1,sICAM-1和sVEGFR-2的水平。免疫吸附测定。通过使用荧光素血管造影术和Scion Image程序测量毛细血管非灌注区域来评估视网膜缺血。用激光耀斑仪测量水耀斑值,并通过光学相干断层扫描检查黄斑水肿。结果BRVO组(12.1个光子计数/毫秒)的水中耀斑值显着高于MH组(4.5个光子计数/毫秒,P≥P≤0.005;ρ≥0.56,P≥0.5)。 0.004;ρ= 0.52,P = 0.006;ρ= 0.47,P = 0.015。在BRVO组中,水斑的值也与中央凹厚度显着相关(ρ= 0.40,P = 0.037)。结论炎症可能通过释放黄斑水肿BRVO患者的炎症因子(VEGF,IL-6,MCP-1和sICAM-1)而引起血管通透性增加和破坏血水屏障。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号